InsidersTradesSigma
Explore the complete record of transactions filed by TATE JEFFREY, Chief Operating Officer. Director active across 1 company, notably Cyclo Therapeutics, Inc.. Cumulatively, 2 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €8k. Activity tracked since 28 April 2022. The latest transaction was disclosed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Jeffrey Tate is the Chief Operating Officer at Cyclo Therapeutics, Inc. He is responsible for managing the daily operations of the company, ensuring efficiency and optimization of operational processes.